SGX Pharmaceuticals, a biotechnology company developing novel cancer therapeutics, cut its range a second time to $6 to $7. This represents a 46% discount to the original range of $11 to $13. The offer size remains the same at 4.0 million shares. CIBC World...read more
In a sign of weak demand, SGX Pharmaceuticals, a biotechnology company developing novel cancer therapeutics, priced 4.0 million shares at $6. The company originally proposed a range of $11 to $13. CIBC World Markets and Piper Jaffray were the lead managers on ...read more
SGX Pharmaceuticals, a biotechnology company developing novel cancer therapeutics, lowered its range to $7 to $8 from $11 to $13 Wednesday morning. The offering size remains unchanged at 4.0 million shares. CIBC World Markets and Piper Jaffray are the joint...read more
SGX Pharmaceuticals, a biotechnology company developing novel cancer therapeutics, announced Wednesday morning that it will offer 4.0 million shares at a range of $11 to $13. Assuming the stock prices at the midpoint, the company will have an initial market...read more
Biotech SGX Pharmaceuticals lowers range again
SGX Pharmaceuticals, a biotechnology company developing novel cancer therapeutics, cut its range a second time to $6 to $7. This represents a 46% discount to the original range of $11 to $13. The offer size remains the same at 4.0 million shares. CIBC World...read more
Biotech SGX Pharmaceuticals prices 4.0 million shares at $6
In a sign of weak demand, SGX Pharmaceuticals, a biotechnology company developing novel cancer therapeutics, priced 4.0 million shares at $6. The company originally proposed a range of $11 to $13. CIBC World Markets and Piper Jaffray were the lead managers on ...read more
Biotech SGX Pharmaceuticals cuts range
SGX Pharmaceuticals, a biotechnology company developing novel cancer therapeutics, lowered its range to $7 to $8 from $11 to $13 Wednesday morning. The offering size remains unchanged at 4.0 million shares. CIBC World Markets and Piper Jaffray are the joint...read more
Biotech SGX Pharmaceuticals sets terms
SGX Pharmaceuticals, a biotechnology company developing novel cancer therapeutics, announced Wednesday morning that it will offer 4.0 million shares at a range of $11 to $13. Assuming the stock prices at the midpoint, the company will have an initial market...read more